U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07195032) titled 'Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients' on Sept. 19.
Brief Summary: The study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to 17 years who have undergone heart transplantation. Subjects who provide permission/assent will receive the commercial MMR vaccine according to product indication and labeling.
Study Start Date: Sept. 11
Study Type: INTERVENTIONAL
Condition:
Heart Transplant Infection Prevention
Intervention:
DRUG: Commercial measles, mumps, and rubella (MM...